NOVOBIO Trademark

Trademark Overview

On Wednesday, February 6, 2019, a trademark application was filed for NOVOBIO with the United States Patent and Trademark Office. The USPTO has given the NOVOBIO trademark a serial number of 88291876. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 13, 2019. The NOVOBIO trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
novobio

General Information

Serial Number88291876
Word MarkNOVOBIO
Filing DateWednesday, February 6, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 13, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
Pseudo MarkNOVO BIO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Wednesday, November 13, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, November 13, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION WRITTEN
Thursday, April 18, 2019ASSIGNED TO EXAMINER
Thursday, February 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

novobio protein containing pharmaceutical treatment preparations disorders diseases complications pharmaceuticals therewith